Base-case results: Probabilistic analysis. by Robert Hodgson (2026294)

Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

“…Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. …”

Significant demographic factors associated with the usefulness of an early warning to take timely preventive action. by Rafdzah Zaki (161810)

Defatting results in decreased gene expression of pro-inflammatory biomarkers. by Siavash Raigani (8067239)

“…<p>Defatting of steatotic livers (DSL) results in significantly decreased gene expression of NF-κB and TNF-α compared to both the SL and LL groups. …”

TF YF-to-S mutants decrease hyphal-specific gene expression. by Collin Ganser (8924843)

SAFA deficiency decreased the chromatin accessibility of antiviral immune genes. by Lili Cao (442626)

SAFA deficiency decreased the chromatin accessibility of antiviral immune genes. by Lili Cao (442626)

Base-case results. by Ping Chen (89712)

The base case analysis. by Wenwang Lang (20293527)

“…</p><p>Results</p><p>In the base-case scenario, adding benmelstobart and anlotinib to chemotherapy increased QALYs by 0.34 at an additional cost of $24,684.07, yielding an ICER of $71,559.84 per QALY. …”

Base-case results. by Shuo Kang (1306860)

“…One-way and probabilistic sensitivity analyses were conducted to estimate the robustness of the model results,</p><p>Results</p><p>In base-case analysis, compared with toripalimab plus chemotherapy and chemotherapy alone, ITH-testing directed therapy could bring additional 0.14 QALYs and 0.29 QALYs, with marginal costs of $3750.75 and $7778.18, resulting in the ICER of $27,353.27/QALY and $26,461.46/QALY, respectively, which lower than the Chinese willingness-to-pay (WTP) threshold. …”

Number of significantly significant (P < 0.05) differentially abundant (SSDA) proteins showing increased or decreased activity (fold change +/- 1.5-fold) relative to time 0 followi... by Peter E. Lillis (12368582)

Base-case results. by Mingxi Xie (19812594)

“…The model time-frame was one-year. Base-case analysis and sensitivity analysis were performed. …”

Base-case analysis. by Akiko Kowada (14659965)

“…The willingness-to-pay (WTP) threshold was set at US$50,000 per QALY gained. In the base-case analysis, HTLV-1 antenatal screening (US$76.85, 24.94766 QALYs, 24.94813 LYs, ICER; US$40,100 per QALY gained) was cost-effective compared with no screening (US$2.18, 24.94580 QALYs, 24.94807 LYs). …”

Plot showing the significant correlation between participant age and QOLI_TOTDIFF. by Roger D. Newman-Norlund (14053467)

Subjects:

Characterization and outcomes of lymphoma cases based on immunophenotype. by Heather Wilson-Robles (731578)

Distribution of proven CPA cases based on their types. by Aishwarya Selvasekhar (20529339)

The MDAE does not vary significantly for different sizes of subsampled graphs. by Niklas Smedemark-Margulies (3539957)

Statistically significant DMRs (<i>fwerArea</i> ≤ 0.05) between severe and mild SS cases located in genes previously identified as hypomethylated in cases relative to non-cases. by Calvin Chi (6240473)

NMN decreased the mRNA level of apoptosis-related genes of aged porcine oocytes. by Leyi Li (5141735)

Subjects: